Entrectinib in patients with ROS1 fusion-positive (ROS1-fp) NSCLC: updated efficacy and safety analysis
Fan, Y. Drilon, A. Chiu, C. H. Bowles, D. W. Loong, H. H. F. Siena, S. Goto, K. Krzakowski, M. Ahn, M. J. Murakami, H.
Fan, Y.
Drilon, A.
Chiu, C. H.
Bowles, D. W.
Loong, H. H. F.
Siena, S.
Goto, K.
Krzakowski, M.
Ahn, M. J.
Murakami, H.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Fan Y, Drilon A, Chiu CH, Bowles DW, Loong HHF, Siena S, et al. Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis. Journal of Thoracic Oncology. 2022 Sep;17(9):S89-S90. PubMed PMID: WOS:000858678100139.